Correlation Between Pliant Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Pliant Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Pliant Therapeutics and Mineralys Therapeutics,
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pliant and Mineralys is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.76 times less risky than Mineralys Therapeutics,. The stock trades about -0.11 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,361 in Mineralys Therapeutics, Common on August 26, 2024 and sell it today you would lose (112.00) from holding Mineralys Therapeutics, Common or give up 8.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Pliant Therapeutics |
| Mineralys Therapeutics, |
Pliant Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Pliant Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |